Research-based pharmaceutical and healthcare company GlaxoSmithKline (GSK) has completed acquisition of Human Genome Sciences (HGS) for $3.6bn on an equity basis, or approximately $3 billion net of cash and debt. With the acquisition, all ...
Tags: GSK, GlaxoSmithKline, Human Genome Sciences
Human Genome Sciences (HGS) has rejected $2.6bn (£1.6bn) takeover bid offered by GlaxoSmithKline (GSK). GSK offered $13 per share, which is 81% premium to HGS closing price on 18 April 2012, of $7.17 per share. HGS has partnered ...
Tags: HGS, GSK, GlaxoSmithKline
Scientists from Britain, Germany and the US have identified the key components of genetic code of wheat, a move which could improve food security. The scientists have identified 96,000 wheat genes and the links between them. The study ...
Tags: wheat, food security, genes, new tools
German Cancer Research Center (DKFZ) and Genetic Immunity have joined hands to develop a DNA-based vaccine to treat Human Papilloma Virus (HPV) infection that causes cervical cancer and other cancers of the anus, penis, vulva, vagina and ...
Tags: DKFZ, DNA-based vaccine, HPV, cervical cancer, cancers
Synthetic Biologics has enterd into second worldwide exclusive channel collaboration with Intrexon to address unmet medical needs of infectious diseases. Synthetic Biologics leverages Intrexon's suite of proprietary technologies for the ...
Tags: Synthetic Biologics, infectious diseases, medical needs
The Anti-Infective Drugs Advisory Committee to the US Food and Drug Administration (FDA) has supported the clinical benefit of GlaxoSmithKline's raxibacumab to treat inhalational anthrax. In addition, the committee also favoured the ...
Tags: The Anti-Infective Drugs, raxibacumab anti-toxin development programme
Calling on the concerned people to develop markets for jute and jute products,Bangladesh Prime Minister Sheikh Hasina said the resources can be best utilized by enhancing exports. Speaking at the opening ceremony of an international ...
Tags: jute, jute products
Cypher Genomics has selected BIOBASE Genome Trax for the whole genome interpretation. As part of the genome interpretation, Cypher Genomics researchers will incorporate the knowledgebase in Genome Trax to assist in interpretation of next ...
Tags: genome interpretation, Trax, genome variants, clinicians
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency virus (HIV). The COBAS TaqMan HIV-1 ...
Tags: Viral Load Test, Dual-target HIV-1 Viral Load Test, Roche
LED-based sequencer to track Salmonella and E.coli 18 Sep 2012 US Food&Drug Administration agrees$17??million contract for sequencing systems to track future outbreaks of potentially harmful pathogens. Illumina,the San Diego company ...
Tags: the San Diego company, LED, Salmonella, E.Coli, MiSeq systems
Developer of"black silicon"laser texturing process for imaging and PV applications signs deal with In-Q-Tel. Laser-textured"black"silicon In-Q-Tel(IQT),the technology venture wing of the US Central Intelligence Agency(CIA),has ...
Tags: Black Silicon, Short-Wave, Sensor, Imaging Systems
GlaxoSmithKline (GSK) has signed a definitive agreement to acquire Human Genome Sciences (HGS) for $14.25 per share in cash. The transaction values HGS at approximately $3.6bn on an equity basis, or approximately $3bn net of cash and ...
Tags: GSK, Human Genome Sciences, HGS
The US Food and Drug Administration(FDA)is set to initiate a five-year project to create a public database of the gene sequences of 100,000 bacteria,as a part of its effort to rapidly identify the source of contamination and bring foodborne ...
Tags: FDA, foodborne outbreaks, five-year project
The Smithsonian's Cooper-Hewitt,National Design Museum will celebrate outstanding achievement in design this fall with its 12th annual National Design Awards program.Today,Cooper-Hewitt Director Bill Moggridge announced the winners and ...
Tags: National Design, Awards, Winner, Cooper-Hewitt